[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"shockwave-therapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:shockwave-therapy":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,43,67,93],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100643050","routine-rehabilitation-versus-shock-wave-therapy-for-scapular-dyskinesis-100643050",false,"NCT07633340","Routine Rehabilitation Versus Shock Wave Therapy for Scapular Dyskinesis","Routine Rehabilitation Versus Shock Wave Therapy for Patients With Scapular Dyskinesis","Inclusion Criteria:\n\n* This study included 100 patients with scapular dyskinesis. The patients were divided into 2 groups: one group was treated with ESWT and routine rehabilitation, and the second group was treated with routine rehabilitation only. Adult patients with scapular dyskinesia who exhibited signs of dyskinesia for at least 6 months before enrolment in the study will be selected.\n\nExclusion Criteria:\n\n1. History of shoulder or thorax trauma or surgery.\n2. The back pain involved the cervical spine and thoracic spine.\n3. Participants with neurologic deficits\n4. history of inflammatory conditions such as ankylosing spondylitis\n\n4- Certain situations where shockwave therapy is not recommended. These include:\n\nAbsolute contraindications:\n\n* Active infection (i.e., osteomyelitis)\n* Malignant tumors, particularly at the treatment site (focused shockwave)\n* Pregnancy\n\nRelative Contraindications:\n\n* The brain or nerve in the treatment focus\n* Treatment focused on the lungs or pleura\n* Significant coagulopathy (increased risk of bleeding, such as haemophilia)\n* Epiphyseal plate in treatment focus\n\nImportant considerations:\n\n* Cardiac pacemakers or other implantable devices\n* Current nonsteroidal anti-inflammatory drug use\n* Current anticoagulation use\n* Recent corticosteroid injections (receiving a steroid injection into the area to be treated within the previous 12 weeks).","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","It has been proposed that altered scapular muscle function can contribute to alterations in shoulder kinematics, which often lead to SD and are frequently associated with other shoulder pathologies, such as RC tears, labrum tears, impingement syndrome, and glenohumeral joint instability. However, whether SD leads to the development of these diseases or is a consequence has yet to be clarified. Changes in scapular kinematics can be attributed not only to altered scapular recruitment patterns (e.g., altered serratus anterior muscle activity) or muscle performance (e.g., force imbalance in the upper and lower trapezius muscles) but also to flexibility deficits in the soft tissue surrounding the scapula, which may restrict normal scapular movement during daily activities and sport- specific movements. Although many studies have investigated the optimal management method, to date, there is no consensus. Conservative approaches involve not only physiotherapy but also other techniques, such as extracorporeal shockwave therapy.",[26,27],"Scapular Dyskinesis","Shockwave Therapy",[29],"Scapular dyskinesis","RECRUITING","2026-06-06",{"date":33,"type":34},"2026-06-10","ACTUAL",{"date":36,"type":34},"2026-06-01",{"date":38,"type":20},"2026-07",{"name":40,"class":41},"Tanta University","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":52,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":42},"100631495","phase-1-shockwave-for-elbow-and-wrist-spasticity-in-people-with-spinal-cord-injury-100631495","NCT07501429","Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury","Pilot Trial of a Novel, Non-invasive Treatment for Upper-limb Spasticity in People With Spinal Cord Injury","Inclusion Criteria:\n\n1. 18 years of age or older.\n2. Have chronic, non-progressive SCI of all levels and severities that occurred greater than 1 year prior to their enrollment.\n3. MAS score of between 1+ and 3 in elbow and wrist flexors of the treated upper limb.\n4. Can be treated with shockwaves. Contraindications include current or recent (within the past 3 months) infection at the site of treatment and severe coagulopathies (e.g. hemophilia).129\n5. No change in antispasmodic medications within the past three months or intended changes over the course of the trial.\n6. Participant is able and willing to comply with the protocol.\n\nExclusion Criteria:\n\n1. History of surgical procedures in the upper extremity\n2. Severe, inflammatory arthritic diseases\n3. Thrombosis\n4. Anticoagulant medication;\n5. Pregnancy\n6. Cancer\n7. Recent history of local injection of botulinum toxin within 6 months, or phenol\u002Falcohol within the 12 months",{"count":51,"type":20},12,[53],"PHASE1","Approximately 305,000 people live with a spinal cord injury (SCI) in the United States. Sixty percent of these individuals have tetraplegia, which can cause significant dysfunction of the arms and hands. One of the consequences of SCI is spasticity - involuntary activation of muscles that can hinder bodily functions and negatively affect participation in various aspects of life. Spasticity can lead to loss of functional independence and activity limitations, cause pain, and lead to mood disorders like depression. It can even interfere with rehabilitation and lead to hospitalization. In people with tetraplegia, spasticity of the arms and hands can have a tremendous impact on independence and quality of life, and thus regaining function in these areas remains a top priority. Unfortunately, spasticity is difficult to treat. Common treatments include physical therapy, including exercise or stretching; medications such as Baclofen; and injections with agents like botulinum toxin (also known as Botox). Botox injections are often implemented alongside other modalities like therapy, yet they are invasive, tend to last for only a few months, and carry potential side effects. One potential non-invasive treatment for upper limb spasticity is focused extracorporeal shockwave therapy (f-ESWT), which involves an external application of high-pressure sound waves, similar to ultrasound. An applicator\u002Fhandpiece is placed on the skin over the spastic muscle and the focused sound waves are applied. f-ESWT carries no long-term side effects with minimal discomfort during application. However, there has been limited research on this treatment option in people with SCI who have arm and hand dysfunction caused by spasticity. The purpose of this study is to fill in that knowledge gap. This will be accomplished by measuring different aspects of spasticity from the perspective of both the clinician and the person with SCI. These will include clinical measures, such as elbow and wrist range of motion, as well as how the treatment impacts the person's functional independence and quality of life. Ultrasound methods will be used to look at the person's muscles to see if any beneficial changes occur in their structure and stiffness. People with SCI who meet eligibility criteria will be invited to the laboratory to receive f-ESWT, which will occur once per week for three consecutive weeks. Treatment will entail application of f-ESWT to the elbow and wrist flexor muscles. Participants will be invited back to the laboratory to have their spasticity measured by a clinician, be asked questions about how their spasticity has impacted their lives, and have their muscles imaged with ultrasound. Findings from this study are expected to generate insight on whether f-ESWT could be a viable treatment option for spasticity of the arms and hands in people with SCI, and if a larger clinical trial is warranted.",[56,57,27],"Spinal Cord Injury","Spasticity","2026-03-26",{"date":60,"type":34},"2026-03-30",{"date":62,"type":20},"2026-04",{"date":64,"type":20},"2028-12",{"name":66,"class":41},"Kessler Foundation",{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":21,"phases":78,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":5},"100579495","the-effects-of-extracorporeal-shock-wave-therapy-in-postsurgical-scars-especially-after-abdominplasty-and-breast-reduction-100579495","NCT06825039","The Effects of Extracorporeal Shock Wave Therapy in Postsurgical Scars Especially After Abdominplasty and Breast Reduction.","The Effects of Extracorporeal Shock Wave Therapy in Different Stages of Scar Formation in Postsurgical Scars Especially After Abdominplasty and Breast Reduction.","Effect of SWT","Inclusion criteria\n\n* Eligible patients aged between 18 and 80 years\n* Dutch or English speaking\n* Patients who had undergone an abdominoplasty resulting in a dermal scar\n* Informed consent (approved by the ethics committee) will be provided before the surgical intervention Exclusion criteria\n* All type of skin diseases or dermatological problems\n* Previous surgery or ESWT intervention at the current scar site\n* Age under 18 years or above 80 years\n* Inability to provide informed consent\n* Expected problems in therapy compliance or follow up\n* Pregnancy","80 Years",{"count":77,"type":20},150,[23],"Scars can be caused by physical trauma, surgical incisions, burn injuries and even acne. Deep cutaneous injuries induce pathological scars. Other factors, such as mechanical loading, bacterial colonization are potential factors thought to underlie human hypertrophic and keloid scar formation or contractures. The effect may include functional impairment and aesthetic disadvantages.\n\nVarious non-invasive mechanical interventions of physical scar management (e.g. extracorporeal shock wave therapy or ESWT) could have a beneficial influence on wound healing and prevention of hypertrophic scars. ESWT considerably improves the appearance and symptoms of hypertrophic scars. However, the mechanism underlying the observed beneficial effects is not well understood. The objective of the first part of the study is to elucidate the mechanism underlying changes in cellular mechanosensitive pathways that are induced by ESWT. This review will introduce the histopathological effects on ESWT during wound healing and scar development.\n\nThe main objective of this study is to determine how much mechanical loading on dermal scars will lead to normal scar healing. The optimal duration, the frequency and the intensity of the applied forces in ESWT to generate a beneficiary effect during different phases of wound healing remains unclear.\n\nIn this study, biopsies from abdomionplasty postsurgical scars will be examined. Thereby it is possible to evaluate the outcomes on a cellular level through assessing the histology of human biopsies under controlled condition. In the second part, the underlying mechanism of ESWT on postsurgical scars will be explored, in different stages of wound healing. Furthermore, the investigators will investigate if changes in physical characteristics (redness, thickness and pliability) in postsurgical scars are associated with changes in reactivity of mechanosensitive pathways. This study will close the gap between the fundamental knowledge on cellular mechanotransduction and the clinical application of mechanotherapy during physical scar management (ESWT).",[81,27],"Scar",[83],"Skin scars, Post surgical, Underlying mechanisms, Shock wave","2025-03-03",{"date":86,"type":34},"2025-03-06",{"date":88,"type":34},"2023-12-20",{"date":90,"type":20},"2027-02",{"name":92,"class":41},"Universiteit Antwerpen",{"id":94,"slug":95,"hasResults":11,"nctId":96,"briefTitle":97,"officialTitle":97,"acronym":4,"eligibilityCriteria":98,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":99,"targetDuration":4,"studyType":21,"phases":101,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":108,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":4},"100573491","comparing-the-effects-of-extracorporeal-shockwave-therapy-and-splinting-in-the-treatment-of-trigger-finger-100573491","NCT06746974","Comparing the Effects of Extracorporeal Shockwave Therapy and Splinting in the Treatment of Trigger Finger","Inclusion Criteria:\n\n* Patients age ≥ 18 years\n* Grade I-III trigger finger patients (patients who has the presence of tenderness over the A1 pulley or painful locking or triggering as they fixed and extended the finger)\n* Patients who consented to participation in the study\n\nExclusion Criteria:\n\n* Trigger thumb\n* The patients who had received previous treatment (steroid injection, ESWT or surgical release)\n* Patients with local infections, malignancies, severe coagulopathy and pregnancy",{"count":100,"type":20},24,[23],"The goal of this study is to compare the effects of extracorporeal shockwave therapy and splinting in the treatment of trigger finger.\n\nParticipants will:\n\nBe randomized into two groups (shockwave group and splint group). Visit the clinic once a week for four weeks for therapy. Keep a diary of their symptoms, which will be reviewed at six weeks.",[104,27],"Trigger Finger",[106,107],"trigger finger","shockwave","NOT_YET_RECRUITING","2024-12-18",{"date":111,"type":34},"2024-12-24",{"date":113,"type":20},"2025-01-15",{"date":115,"type":20},"2026-11-30",{"name":117,"class":41},"Mahidol University"]